NCT02087462

Brief Summary

This multicenter randomized controlled trial (RCT) will evaluate the therapeutic effectiveness and health-economics of electroacupuncture for sciatica due to intervertebral disc displacement in 3 compared groups: electroacupuncture, electroacupuncture plus traction, electroacupuncture plus traction and medication.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
324

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

February 28, 2014

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 14, 2014

Completed
18 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

March 14, 2014

Status Verified

March 1, 2014

Enrollment Period

2.2 years

First QC Date

February 28, 2014

Last Update Submit

March 13, 2014

Conditions

Keywords

SciaticaElectroacupunctureIntervertebral disc displacement

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale(VAS) of Leg Pain

    Change from baseline in VAS of Leg Pain at 6 weeks

Secondary Outcomes (6)

  • Visual Analog Scale(VAS) of Low Back Pain

    Change from baseline in VAS of Low Back Pain at 6 weeks

  • Simplified McGill Pain Questionnaire (ST-MPQ)

    Change from baseline in ST-MPQ at 6 weeks

  • Improved Roland Functional questionaire(RDQ)

    Change from baseline in RDQ at 6 weeks

  • Likert Overall Recovery Self Rating Scale (7 points)

    Change from baseline in Likert Overall Recovery Self Rating Scale at 6 weeks

  • The Medical Outcomes Study 36-Item Short -Form Health Survey Questionnaire (SF-36)

    Change from baseline in SF-36 at 6 weeks

  • +1 more secondary outcomes

Study Arms (3)

Electroacupuncture (EA)

EXPERIMENTAL

Use Electroacupuncture only

Other: Electroacupuncture (EA)

EA + Traction

OTHER

Use electroacupuncture and traction together

Other: Electroacupuncture (EA)Other: Traction

EA + Traction + Oral Medication

OTHER

Combine electroacupuncture, traction and oral medication (Voltaren and Vitamin B1) together for treatment

Other: Electroacupuncture (EA)Other: TractionDrug: VoltarenDrug: Vitamin B1

Interventions

Main acupoints: Da chang shu (BL25), Huan tiao (GB30), bilateral Jiaji point of attacked lumbar vertebra, Ashi points, modifying points according to different patterns. Electroacupuncture: choose the dilatational wave, frequency is 2Hz/100Hz, electric current ranges from 0.1mA to 1.0mA, 30 mins per time. Treatment frequency: 5 times per week in the first 2 weeks, 3 times per week in the 3rd and 4th week, 2 times per week in the 5th and 6th week. Duration: 6 weeks.

EA + TractionEA + Traction + Oral MedicationElectroacupuncture (EA)

An electric pelvis traction in supine position will be applied. The treatment frequency and duration are the same as EA.

EA + TractionEA + Traction + Oral Medication

Medication: 50 mg, twice per day Treatment frequency: In the first 2 weeks, take medicine for continuous 5 days with a 2-day interval each week; in the 3rd and 4th week, take medicine every 2 days, totally 3 times each week; in the 5th and 6th week, take medicine every 3 days, totally 2 times each week. Duration: 6 weeks.

Also known as: Voltaren or Votalin.
EA + Traction + Oral Medication

Medication: 10mg, twice per day. Treatment frequency: In the first 2 weeks, take medicine for continuous 5 days with a 2-day interval each week; in the 3rd and 4th week, take medicine every 2 days, totally 3 times each week; in the 5th and 6th week, take medicine every 3 days, totally 2 times each week. Duration: 6 weeks.

Also known as: Vitamin B1 or Thiamin or Thiamine or Aneurin
EA + Traction + Oral Medication

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who meet the clinical diagnosis of sciatica caused by intervertebral disc displacement;
  • Male or female, aged 18-65;
  • Have completed informed consent form.

You may not qualify if:

  • Patients with sciatica caused by diseases such as piriformis syndrome, thickening of ligamentum flavus, acute lumbar strain, contusion, congenital spina bifid, lumbar and sacrum deformity, lumbar sacral vertebra joint disorder or proliferative osteoarthrosis;
  • Patients with urinary and fecal incontinence caused by acute lumbar disc herniation, huge or central type lumbar disc herniation sufferer in need of surgery;
  • Patients who fail to finish the basic treatment course, or have poor adherence;
  • Patients having a poor state, particularly unconsciousness, psychopath, severe osteoporosis, concurrent infection or bleeding susceptibly, or accompany with primary diseases in cardiovascular, digestion or hemopoietic systems and viscera as kidney, liver;
  • Pregnant or lactating women;
  • Patients in other clinical research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chengdu university of Traditonal Chinese Medcine

Chengdu, Sichuan, 610075, China

RECRUITING

MeSH Terms

Conditions

SciaticaIntervertebral Disc Displacement

Interventions

ElectroacupunctureTractionDiclofenacThiamine

Condition Hierarchy (Ancestors)

Sciatic NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNeuralgiaPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSpinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, Anatomical

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsAcupuncture TherapyComplementary TherapiesElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationTranscutaneous Electric Nerve StimulationAnalgesiaAnesthesia and AnalgesiaAnesthesiaOrthopedic ProceduresSurgical Procedures, OperativePhenylacetatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsThiazolesSulfur CompoundsAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPyrimidines

Study Officials

  • Xi Wu, A.P.

    School of Acupunture& Tuina, Chengdu University of Traditional Chinese Medicine

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 28, 2014

First Posted

March 14, 2014

Study Start

January 1, 2012

Primary Completion

April 1, 2014

Study Completion

June 1, 2014

Last Updated

March 14, 2014

Record last verified: 2014-03

Locations